MedTrace Logo

A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo

NCT05752032 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2026-03-27

No results posted yet for this study

Summary

This is an observational study of the long term safety and efficacy of ICM-203.

Conditions

  • Osteoarthritis, Knee

Interventions

GENETIC

ICM-203

Long term follow-up

DRUG

Placebo

Long term follow-up

Sponsors & Collaborators

  • ICM Co. Ltd.

    lead INDUSTRY

Principal Investigators

  • Alison Heald, MD · ICM Co. Ltd.

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-16
Primary Completion
2028-12-31
Completion
2028-12-31
FDA Drug
Yes

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05752032 on ClinicalTrials.gov